Abstract:Sphingosine kinase (SK) catalyzes the formation of sphingosine 1-phosphate (S1P), a lipid messenger that plays an important role in a variety of mammalian cell processes, including inhibition of apoptosis and stimulation of cell proliferation. Basal levels of SIP in cells are generally low but can increase rapidly when cells are exposed to various agonists through rapid and transient activation of SK activity. To date, elucidation of the exact signaling pathways affected by these elevated S1P levels has relied on the use of SK inhibitors that are known to have direct effects on other enzymes in the cell. Furthermore, these inhibitors block basal SK activity, which is thought to have a housekeeping function in the cell. To produce a specific inhibitor of SK activation we sought to generate a catalytically inactive, dominant-negative SK. This was accomplished by site-directed mutagenesis of Gly(82) to Asp of the human SK, a residue identified through sequence similarity to the putative catalytic domain of diacylglycerol kinase. This mutant had no detectable SK activity when expressed at high levels in HEK293T cells. Activation of endogenous SK activity by tumor necrosis factor-alpha (TNF alpha), interleukin-lp, and phorbol esters in HEK293T cells was blocked by expression of this inactive sphingosine kinase (hSK(G82D)), Basal SK activity was unaffected by expression of hSR(G82D). Expression of hSK(G82D) had no effect on TNF alpha -induced activation of protein kinase C and sphingomyelinase activities. Thus, hSK(G82D) acts as a specific dominant-negative SK to block SK activation. This discovery provides a powerful tool for the elucidation of the exact signaling pathways affected by elevated S1P levels following SK activation. To this end we have employed the dominant-negative SK to demonstrate that TNF alpha activation of extracellular signal-regulated kinases 1 and 2 (ERK1,2) is dependent on SK activation.

Sphingosine Kinase-1 Enhances Endothelial Cell Survival Through a PECAM-1–dependent Activation of PI-3K/Akt and Regulation of Bcl-2 Family Members

Activation of Sphingosine Kinase-1 Mediates Induction of Endothelial Cell Proliferation and Angiogenesis by Epoxyeicosatrienoic Acids.

Interplay between the SAFE and the sphingolipid pathway for cardioprotection

Cancer Therapy : Preclinical Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI 3 K / Akt / NFk B Pathway in Human Non – Small Cell Lung Cancer

SIRT1 Mediates Sphk1/S1P-induced Proliferation and Migration of Endothelial Cells.

Data from Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

An Oncogenic Role of Sphingosine Kinase

Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia

Phosphorylation-dependent Translocation of Sphingosine Kinase to the Plasma Membrane Drives Its Oncogenic Signalling

Post-translational regulation of sphingosine kinases

Angiopoietin-1 Protects Mesenchymal Stem Cells Against Serum Deprivation and Hypoxia-Induced Apoptosis Through the PI3K/Akt Pathway

Identification of CISK, a New Member of the SGK Kinase Family That Promotes IL-3-dependent Survival.

Expression of A Catalytically Inactive Sphingosine Kinase Mutant Blocks Agonist-Induced Sphingosine Kinase Activation - A Dominant-Negative Sphingosine Kinase

Activation of Sphingosine Kinase by Tumor Necrosis Factor-α Inhibits Apoptosis in Human Endothelial Cells

Sphingosine 1-Phosphate Promotes Mesenchymal Stem Cell-Mediated Cardioprotection Against Myocardial Infarction Via ERK1/2-MMP-9 and Akt Signaling Axis.

Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy

Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells

Human Sphingosine Kinase: Purification, Molecular Cloning and Characterization of the Native and Recombinant Enzymes

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid